biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > British Columbia Securities Commission!!

<< Previous

Bullboard Posts

Next >>

Comment by fuzzyjron Feb 07, 2023 4:42pm

171 Views

Post# 35272936

RE:RE:RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!

great summary imo! The truth works.

still say it was a brutal deal/merge/dilution etc wise but it's quite obvious now both companys/CEO's etc had there backs up against the wall & were in survival mode.

Not sure what the shareholders on the other side of the deal were thinking with the "no" vote given their financial shape & no plan b?? & few even show up to vote??

Yep ,the way it looks right now,is both CEO's couldn't have worked any more majic/raised significant coin etc.

In this moment what I first thought was a "brutal deal" looks pretty good right now & for all.
glta

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market